| SBUX |
Report |
U.S. SSS (%) |
BEAT |
pred ~+6.5% vs. cons +5.77% |
MEDIUM |
| SBUX |
Report |
EPS Non-GAAP ($) |
BEAT |
pred ~$0.68 vs. cons $0.652 |
MEDIUM |
| SBUX |
Report |
Total Net Revenues |
IN-LINE |
pred ~$9.25B vs. cons $9.175B |
MEDIUM |
| SBUX |
Guide |
FY2026 EPS (FY2026) |
BETTER |
guide ~$2.40-$2.55 vs. cons $2.397 |
MEDIUM |
| SBUX |
Guide |
FY2026 U.S. SSS (FY2026) |
BETTER |
guide ~'6%+' vs. cons +5.28% |
MEDIUM |
| SBUX |
Guide |
FY2026 Operating Margin (FY2026) |
UNCHANGED |
guide reaffirm 'slight YoY growth' vs. cons in-line |
HIGH |
| SBUX |
Guide |
FY2026 Revenue (FY2026) |
UNCHANGED |
guide reaffirm 'roughly flat YoY' vs. cons $37.84B |
HIGH |
| SBUX |
Return |
Day-1 residual (stock − beta × S&P 500) |
+3.5% |
— |
MEDIUM |
| SBUX |
Return |
5-day cumulative residual |
+4.5% (STABILIZE) |
STABILIZE — day-1 move holds; modest follow-through from EPS estimate revisions, capped by revenue guidance and 'expected turnaround' dynamic |
MEDIUM |